1-3 of 3
Enrico Derenzini
Close
Sort by
Journal Articles

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL

Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila E. Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano Pileri, Enrico Derenzini
Journal: Blood Advances
Blood Adv (2023) 7 (4): 630–643.
https://doi.org/10.1182/bloodadvances.2022007825
Published: 2023
Includes: Supplemental data
Journal Articles

The identification of TCF1 + progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade

Valentina Tabanelli, Federica Melle, Giovanna Motta, Saveria Mazzara, Marco Fabbri, Claudio Agostinelli, Angelica Calleri, Marcello Del Corvo, Stefano Fiori, Daniele Lorenzini, Alessandra Cesano, Annalisa Chiappella, Umberto Vitolo, Enrico Derenzini, Gabriel K. Griffin, Scott J. Rodig, Anna Vanazzi, Elena Sabattini, Corrado Tarella, Maria Rosaria Sapienza, Stefano A. Pileri
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4634–4644.
https://doi.org/10.1182/bloodadvances.2022007046
Published: 2022
Includes: Supplemental data
Journal Articles

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies

Clinical Trials & Observations
Matthew S. Davids, Owen A. O’Connor, Wojciech Jurczak, Felipe Samaniego, Timothy S. Fenske, Pier Luigi Zinzani, Manish R. Patel, Nilanjan Ghosh, Bruce D. Cheson, Enrico Derenzini, Danielle M. Brander, James A. Reeves, Wanda Knopińska-Posłuszny, John N. Allan, Tycel Phillips, Paolo F. Caimi, Ewa Lech-Maranda, John M. Burke, Richy Agajanian, Ruth Pettengell, Lori A. Leslie, Chan Y. Cheah, Gustavo Fonseca, James Essell, Julio C. Chavez, John M. Pagel, Jeff P. Sharman, Yanzhi Hsu, Hari P. Miskin, Peter Sportelli, Michael S. Weiss, Ian W. Flinn
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5332–5343.
https://doi.org/10.1182/bloodadvances.2021005132
Published: 2021
Includes: Supplemental data